Amount awarded from CPRIT grant.

No definition available.

Name:	scpx_AmountAwardedFromCpritGrant
Namespace Prefix:	scpx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount the company is required to match of each dollar of grant.

+ References

No definition available.

+ Details

Name:	scpx_AmountOfMatchForEveryDollarOfGrant
Namespace Prefix:	scpx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

N/A

+ References

No definition available.

+ Details

Name:	scpx_CdmoRevenueAbstract
Namespace Prefix:	scpx_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of Contribution to be made in matching funds over the life of a project.

+ References

No definition available.

+ Details

Name:	scpx_CpritFundingPlanEmployerMatchingContributionsTotalAmount
Namespace Prefix:	scpx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

N/A

+ References

No definition available.

+ Details

Name:	scpx_GrantRevenueAbstract
Namespace Prefix:	scpx_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

N/A

+ References

No definition available.

+ Details

Name:	scpx_LicenseRevenueAbstract
Namespace Prefix:	scpx_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of revenue received as milestone payments.

+ References

No definition available.

+ Details

Name:	scpx_LicenseRevenueMilestonePaymentsReceived
Namespace Prefix:	scpx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Represents information relating to the total number of customers.

+ References

No definition available.

+ Details

Name:	scpx_NumberOfCustomers
Namespace Prefix:	scpx_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of vials for which manufacturing conversion is completed.

+ References

No definition available.

+ Details

Name:	scpx_NumberOfVialsManufacturingConversionCompleted
Namespace Prefix:	scpx_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount of sale consideration with respect to Patent Rights Sale and Assignment Agreement.

+ References

No definition available.

+ Details

Name:	scpx_PatentRightsSaleAndAssignmentAgreementSaleConsideration
Namespace Prefix:	scpx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of process development contract liability.

+ References

No definition available.

+ Details

Name:	scpx_ProcessDevelopmentContractLiability
Namespace Prefix:	scpx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of process development contract liability net changes to contract balance recognized since beginning of period due to amounts collected.

+ References

No definition available.

+ Details

Name:	scpx_ProcessDevelopmentContractLiabilityNetChangeToContractBalance
Namespace Prefix:	scpx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of process development contract liability reclassified to revenue as a result of performance obligations satisfied.

+ References

No definition available.

+ Details

Name:	scpx_ProcessDevelopmentContractLiabilityReclassificationToRevenue
Namespace Prefix:	scpx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

N/A

+ References

No definition available.

+ Details

Name:	scpx_ProcessDevelopmentRevenueAbstract
Namespace Prefix:	scpx_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of process development revenue recognized.

+ References

No definition available.

+ Details

Name:	scpx_ProcessDevelopmentRevenueRecognized
Namespace Prefix:	scpx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

N/A

+ References

No definition available.

+ Details

Name:	scpx_ProductSalesAbstract
Namespace Prefix:	scpx_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Royalty percentage after threshold is met.

+ References

No definition available.

+ Details

Name:	scpx_RoyaltyPercentageAfterThresholdIsMet
Namespace Prefix:	scpx_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Threshold amount for match of grant.

+ References

No definition available.

+ Details

Name:	scpx_ThresholdAmountForMatchOfGrant
Namespace Prefix:	scpx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 310
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481990/310-10-45-2

+ Details

Name:	us-gaap_AccountsReceivableNetCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-21

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 20
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482907/825-10-50-20

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 18
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-18

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 275
-SubTopic 10
-Section 50
-Paragraph 20
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482861/275-10-50-20

+ Details

Name:	us-gaap_ConcentrationRiskPercentage1
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 8
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-8

+ Details

Name:	us-gaap_ContractWithCustomerLiabilityRevenueRecognized
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 7
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-7

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 205
-SubTopic 20
-Name Accounting Standards Codification
-Section 50
-Paragraph 5B
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483499/205-20-50-5B

+ Details

Name:	us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 270
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 1
-Subparagraph (i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482964/270-10-50-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (ee)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 32
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-32

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Topic 924
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-5

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 30
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 42
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-42

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 22
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 4
-Subparagraph (a)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-4

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of transaction price allocated to performance obligation that has not been recognized as revenue.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 13
-Subparagraph (a)
-SubTopic 10
-Topic 606
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479806/606-10-50-13

+ Details

Name:	us-gaap_RevenueRemainingPerformanceObligation
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Details

Name:	us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_MajorCustomersAxis=scpx_OneCustomerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_MajorCustomersAxis=scpx_TwoCustomersMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_MajorCustomersAxis=scpx_ThreeCustomersMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=scpx_ShattuckLabsIncShattuckMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=scpx_KopfkinoIpLlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=scpx_PatentRightsSaleAndAssignmentAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=scpx_AnthimVialsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=scpx_PelicanTherapeuticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_ProductOrServiceAxis=us-gaap_GrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TransactionTypeAxis=scpx_TrancheOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TransactionTypeAxis=scpx_TrancheTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TransactionTypeAxis=scpx_TrancheThreeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Revenue (Details)			1 Months Ended						12 Months Ended
Revenue (Details)	Jan. 29, 2024 USD ($)	Sep. 13, 2023 USD ($) item	Apr. 30, 2023 USD ($)	Mar. 31, 2023 USD ($)	Dec. 31, 2019 USD ($)	Oct. 31, 2017 USD ($)	May 31, 2017 USD ($)	Jun. 30, 2016 USD ($)	Dec. 31, 2024 USD ($) customer	Dec. 31, 2023 USD ($) customer	Dec. 31, 2022 USD ($)
Grant Revenue
Revenue									$ 6,243,022	$ 6,994,838
CDMO revenue
Process development revenue recognized									6,000,000	6,600,000
Changes in contract liabilities
Process development contract liabilities, beginning of period									2,389,441	1,618,308
Reclassification to revenue as the result of performance obligations satisfied									(4,740,132)	(6,358,617)
Net change to contract balance recognized since beginning of period due to amounts collected									3,816,785	7,129,750
Process development contract liabilities, end of period									1,466,094	2,389,441
Recognized revenue									2,200,000	1,200,000
Performance obligations									800,000
Accounts receivable									$ 143,469	$ 375,192	$ 81,456
Total recognized revenue \| Customer Concentration Risk \| One customer
CDMO revenue
Number of customers \| customer									1	1
Concentration risk, percentage									38.00%	74.00%
Total recognized revenue \| Customer Concentration Risk \| Two customers
CDMO revenue
Number of customers \| customer										2
Concentration risk, percentage										86.00%
Total recognized revenue \| Customer Concentration Risk \| Three customers
CDMO revenue
Number of customers \| customer									3
Concentration risk, percentage									65.00%
Shattuck
License Revenue
Proceeds from milestone payment				$ 100,000
Consideration	$ 1,000,000
Shattuck \| Kopfkino IP, LLC \| Kopfikino - Patent Agreement
License Revenue
Consideration	$ 1,000,000
ANTHIM Vials
Product Sales
Number of vials, manufacturing conversion \| item		23,732
Revenue		$ 6,700,000
Pelican Therapeutics, Inc. \| Grant and contract revenue
Grant Revenue
Revenue			$ 1,500,000							$ 15,200,000
Amount the company is required to match of each dollar of grant									$ 0.5
Threshold Amount For Match Of Grant									1
Contribution to be made by Pelican									$ 7,600,000
Pelican Therapeutics, Inc. \| Grant and contract revenue \| Maximum
Grant Revenue
Amount awarded from CPRIT grant								$ 15,200,000
Royalty Percentage After Threshold Is Met									1.00%
Pelican Therapeutics, Inc. \| Grant and contract revenue \| Tranche 1
Grant Revenue
Revenue							$ 1,800,000
Pelican Therapeutics, Inc. \| Grant and contract revenue \| Tranche 2
Grant Revenue
Revenue						$ 6,500,000
Pelican Therapeutics, Inc. \| Grant and contract revenue \| Tranche 3
Grant Revenue
Revenue					$ 5,400,000